Bank of Montreal
OREX

Bank of Montreal’s Orexigen Therapeutics, Inc. OREX Stock Holding History

Bank of Montreal’s Portfolio OREX Stock Details OREX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,000
Closed -$121K – 4447
2014
Q4 		$121K Sell
2,000
-11,030
-85% -$554K ﹤0.01% 2685
2014
Q3 		$555K Buy
13,030
+4,480
+52% +$241K ﹤0.01% 2030
2014
Q2 		$528K Buy
+8,550
New +$497K ﹤0.01% 2054

Other funds holding OREX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
OWIM
Old West Investment Management Los Angeles, California $944M AUM 90.26% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of Montreal's OREX Position: Q1 2018 in Review

Bank of Montreal sold out of Orexigen Therapeutics, Inc. (OREX) in Q1 2018, closing a stake of 74,100 shares — an estimated $95K sold.

Bank of Montreal first reported a position in OREX in Q2 2013 and held it in 12 quarters. The position peaked at $304K in Q1 2017. 27 funds tracked by Wall St. Rank hold OREX as of Q1 2018.

  • Bank of Montreal reported no remaining Orexigen Therapeutics, Inc. position as of Q1 2018 after selling out during the quarter.
  • Bank of Montreal sold 74,100 Orexigen Therapeutics, Inc. shares in Q1 2018, an estimated $95K.
  • Bank of Montreal first reported a position in Orexigen Therapeutics, Inc. in Q2 2013 and held it in 12 quarters.
  • Bank of Montreal's Orexigen Therapeutics, Inc. position peaked at $304K in Q1 2017.
  • 27 funds tracked by Wall St. Rank held Orexigen Therapeutics, Inc. as of Q1 2018.

Based on Bank of Montreal's 13F filing for Q1 2018, filed 13 Apr 2018.